Lifecore Biomedical informa las ganancias trimestralmente. Estos informes de ganancias trimestrales ofrecen a los inversores una visión de los resultados financieros de una empresa durante un período de 3 meses. Los informes de ganancias casi siempre incluyen resultados de EPS e ingresos.
Analice el historial de beneficios de Lifecore Biomedical utilizando filtros y clasificaciones avanzadas.
Get Alert | |||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|
LFCR | Lifecore Biomedical | -$0.53 | -$0.32 | — | — | $24.70M | $26.35M | — | — | 10/03/2025 | |
LFCR | Lifecore Biomedical | -$0.20 | -$0.10 | -$0.06 | 33.33% | $37.89M | $35.36M | $36.44M | 2.61% | 08/07/2025 | |
LFCR | Lifecore Biomedical | $0.40 | -$0.15 | -$0.28 | -86.67% | $35.70M | $33.23M | $35.15M | 5.79% | 04/03/2025 | |
LFCR | Lifecore Biomedical | $0.39 | -$0.30 | -$0.25 | 19.35% | $30.15M | $29.75M | $32.56M | 9.46% | 01/02/2025 | |
LFCR | Lifecore Biomedical | -$0.41 | -$0.47 | -$0.53 | -15.22% | $24.52M | $23.19M | $24.70M | 6.53% | 10/04/2024 | |
LFCR | Lifecore Biomedical | -$0.11 | -$0.26 | -$0.20 | 23.08% | $31.15M | $24.42M | $37.89M | 55.14% | 08/26/2024 | |
LFCR | Lifecore Biomedical | -$0.37 | -$0.26 | $0.40 | — | $26.54M | $24.42M | $35.70M | — | 08/09/2024 | |
LFCR | Lifecore Biomedical | -$0.31 | -$0.06 | $0.39 | 657.14% | $21.86M | $35.77M | $30.15M | 1.31% | 08/09/2024 | |
LFCR | Lifecore Biomedical | -$0.23 | -$0.07 | -$0.41 | -57.69% | $23.72M | $29.76M | $24.52M | 0.42% | 08/09/2024 | |
LFCR | Lifecore Biomedical | -$0.01 | -$0.37 | -$0.11 | 7027.03% | $47.63M | $29.02M | $31.55M | 870.43% | 08/31/2023 | |
LFCR | Lifecore Biomedical | -$0.06 | -$0.13 | -$0.22 | -69.23% | $37.40M | $28.00M | $27.60M | -1.43% | 06/01/2023 | |
LFCR | Lifecore Biomedical | -$0.25 | $0.03 | -$0.24 | -900.00% | $43.45M | $54.54M | $38.80M | -28.86% | 03/16/2023 | |
LFCR | Lifecore Biomedical | -$0.23 | -$0.13 | -$0.32 | -146.15% | $128.79M | $42.74M | $43.35M | 1.44% | 10/06/2022 | |
LFCR | Lifecore Biomedical | $0.07 | -$0.01 | -$0.01 | 0.00% | $139.83M | $45.55M | $47.63M | 4.56% | 08/10/2022 | |
LFCR | Lifecore Biomedical | -$0.09 | — | -$0.08 | — | $137.78M | $48.41M | $53.07M | 9.63% | 04/05/2022 | |
LFCR | Lifecore Biomedical | $0.02 | -$0.04 | -$0.25 | -525.00% | $130.90M | $42.93M | $43.45M | 1.22% | 01/05/2022 | |
LFCR | Lifecore Biomedical | -$0.11 | -$0.12 | -$0.23 | -91.67% | $135.64M | $129.12M | $128.79M | -0.26% | 09/29/2021 | |
LFCR | Lifecore Biomedical | $0.05 | -$0.01 | $0.07 | 800.00% | $156.13M | $124.58M | $139.83M | 12.24% | 07/28/2021 | |
LFCR | Lifecore Biomedical | $0.04 | $0.02 | -$0.09 | -550.00% | $152.93M | $139.75M | $137.78M | -1.41% | 04/07/2021 | |
LFCR | Lifecore Biomedical | -$0.16 | $0.01 | $0.02 | 100.00% | $142.59M | $134.24M | $130.90M | -2.49% | 01/06/2021 | |
LFCR | Lifecore Biomedical | -$0.16 | -$0.11 | -$0.11 | 0.00% | $138.71M | $127.86M | $135.64M | 6.09% | 10/06/2020 |
Trimestre Fiscal | Fecha reportada | EPS real | EPS estimado | Sorpresa % |
---|---|---|---|---|
Q4 | 2025-08-07 | $-0.06 | $-0.10 | 33.3 % |
Q3 | 2025-04-03 | $-0.28 | $-0.15 | -86.7 % |
Q2 | 2025-01-02 | $-0.25 | $-0.30 | 19.4 % |
Q1 | 2024-10-04 | $-0.53 | $-0.47 | -15.2 % |
Trimestre Fiscal | Fecha reportada | Ingresos reales | Ingresos estimados | Sorpresa % |
---|---|---|---|---|
Q4 | 2025-08-07 | $36.44M | $35.36M | 2.61 % |
Q3 | 2025-04-03 | $35.15M | $33.23M | 5.79 % |
Q2 | 2025-01-02 | $32.56M | $29.75M | 9.46 % |
Q1 | 2024-10-04 | $24.71M | $23.19M | 6.53 % |
Está previsto que Lifecore Biomedical (LFCR) presente resultados el octubre 3, 2025. Los últimos resultados se publicaron el agosto 7, 2025 para el Q4.
El BPA real fue de $-0.06, que superó la estimación de $-0.09.
Los ingresos reales fueron $36.4M, que superó la estimación de $35.4M.
Explora Estimaciones de beneficios, BPA e ingresos sobre todos los valores.